Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AbundRX vs Regenics

AbundRX
Graded #181

Higher grade

vs+2.5999999999999943
Regenics
Graded #247

Lower grade

The verdict

AbundRX takes it — 66.6/100 to 64/100.

AbundRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. AbundRX (Abundant Wellness) is an online medical weight-care platform connecting patients with licensed clinicians for compounded GLP-1 treatment.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAbundRX +13
67
54
Dose & formulationRegenics +13
64
77
Clinical oversightAbundRX +5
79
74
Labs & monitoringEven
53
53
FulfillmentAbundRX +8
74
66
Contract termsEven
55
55
AbundRX · left barRegenics · right bar

The numbers

MetricAbundRXRegenics
WeighScore66.6/10064/100
GradeCC
Scorecard rank#181#247
Semaglutide$179/mo (compounded)$199/mo (starting dose, compounded)
Tirzepatide$279/mo (compounded)$279/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
AbundRX

Graded #181 · C

Strengths

  • Two clear compounded GLP-1 pathways with transparent pricing — semaglutide $179/mo and tirzepatide $279/mo
  • Fast, free shipping and a simple few-minute online health assessment
  • Provider-guided care connecting patients with licensed US clinicians
  • Publishes Terms, Privacy, and Refund policies

Where it loses points

  • Claims LegitScript certification in text but displays no verifiable seal or listing
  • Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Compounding pharmacy not named; no HIPAA notice found; state availability not published
  • Heavily hedged marketing language ('may include', 'helping connect patients') — reads like a lead-generation platform
Regenics

Graded #247 · C

Strengths

  • Hybrid model — in-office visits near Tarzana, CA plus national telemed
  • Physical address published with a Google Maps link
  • Phone support published — uncommon for DTC-only competitors
  • Office hours clearly stated
  • $139/mo first-month intro is competitive with the low end of the market

Where it loses points

  • 503A pharmacy partner not named
  • LegitScript certification not mentioned
  • Full states-served list not disclosed
  • 503A vs 503B designation not specified
  • FDA compounded-medication disclaimer not visible on the homepage

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard